HHS 5

Also Known As:

HHS-5; poly-hexuronyl-(1-4)-D-(N-acetyl)(N-sulfonyl)glucosamine 6-O-sulfate sodium salt; Hexurono-2-(acetylamino)-2-deoxy-D-gluco-2-(sulfoamino)-2-deoxy-D-glucan, hydrogen sulfate (ester), sodium salt

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Carbohydrates: 22023
- Polysaccharides: 15383
  - Glycosaminoglycans: 5640
    - Heparitin Sulfate: 1890
      - HHS 5: 1

Experts

1.	De Cock, Erwin: 1 article (03/2016)
2.	Hauser, Nik: 1 article (03/2016)
3.	Knoop, Ann: 1 article (03/2016)
4.	Kritikou, Persefoni: 1 article (03/2016)
5.	Millar, Douglas: 1 article (03/2016)
6.	Pivot, Xavier: 1 article (03/2016)
7.	Verma, Sunil: 1 article (03/2016)

Related Diseases

1.	Sudden Infant Death (SID) 03/01/2016 - "Active HCP time was reduced by a mean of 13 min per session with the SC SID (range across countries: 4-16; P < 0.0001) and 17 min with the SC HHS (5-28; P < 0.0001) versus IV. SC trastuzumab, delivered via SID or HHS, saved patient chair and active HCP times versus IV infusion, supporting a transition to either SC method."

Related Drugs and Biologics

1.	Trastuzumab (Herceptin)